Etodolac
Etodolac Price range: $ 46,00 through $ 390,00
Back to products
Eulexin
Eulexin Price range: $ 51,00 through $ 475,00

Eukroma Cream

Price range: $ 47,00 through $ 151,00

Eukroma Cream is a highly effective topical treatment designed to address various types of skin hyperpigmentation. Formulated with hydroquinone, this cream works by gradually lightening dark patches to promote a more balanced and uniform skin tone. It is widely used to diminish the appearance of melasma, age spots, and freckles caused by sun exposure or hormonal changes. The cream features a smooth consistency that absorbs easily into the skin, making it suitable for targeted application on affected areas. Consistent use helps restore a radiant complexion by significantly reducing the visibility of stubborn discolorations.

Active substance: Hydroquinone
SKU: Eukroma Cream Category:
Delivery: 5–21 days (depending on the shipping method)
Extra 10% discount with coupon: IT4K6SVM

Each dosage option has its own packaging choices.

Description

Eukroma Cream belongs to the class of dermatological depigmenting agents containing hydroquinone as its primary active pharmaceutical ingredient. In the United States, topical hydroquinone formulations at prescription concentrations are regulated by the U.S. Food and Drug Administration (FDA) and are available exclusively pursuant to a valid prescription from a licensed healthcare professional. This topical medication is indicated for the temporary reduction of skin hyperpigmentation associated with various dermatological conditions.

Treatment with Eukroma Cream requires professional medical oversight to evaluate skin sensitivity, monitor clinical response, and mitigate the risk of adverse cutaneous events. Patients should utilize this preparation strictly under the supervision of a dermatologist or qualified physician to ensure both therapeutic efficacy and safety during the treatment course.

Basic Information Summary
Property Details
Active Ingredient Hydroquinone
Therapeutic Class Depigmenting Agent (Skin-Bleaching Agent)
Dosage Form Topical Cream
Route of Administration Cutaneous (Topical application only)
Primary Indication Gradual bleaching of hyperpigmented skin lesions
Prescription Status Prescription Only (Rx)
Storage Conditions Store at 20°C to 25°C (68°F to 77°F); protect from light

Clinical Overview and Pharmacodynamics

How the drug works

Eukroma Cream exerts its depigmenting action primarily by inhibiting the enzymatic conversion of tyrosine to 3,4-dihydroxyphenylalanine (DOPA) within epidermal melanocytes. The active constituent, hydroquinone, acts as a competitive inhibitor of tyrosinase, the rate-limiting enzyme in the melanogenesis pathway. By suppressing tyrosinase activity, the cream reduces the cellular production of melanin pigment. Secondary cellular mechanisms include the structural alteration of melanosomes and the selective destruction of active melanocytes, which decreases total melanin density in hyperpigmented areas over time. The onset of visible depigmentation depends on individual epidermal turnover rates and baseline melanin levels.

What it’s used for

Eukroma Cream is indicated for the topical treatment of hyperpigmented skin conditions characterized by excessive melanin deposition. Approved clinical uses include the management of melasma (chloasma), senile lentigines (age spots), solar lentigines (sun freckles), and post-inflammatory hyperpigmentation resulting from cutaneous trauma, acne, or inflammatory skin disorders. Off-label indications–such as off-label preoperative preparation before chemical peels or laser resurfacing to prevent post-procedural hyperpigmentation–must be specifically evaluated, authorized, and monitored by a qualified healthcare professional, as these uses fall outside the standard primary FDA-approved prescribing guidelines.

Dosing schedule

The dosing schedule for Eukroma Cream must be individualized according to patient response and skin tolerance. Typically, a thin layer of cream is applied topically to the specified hyperpigmented areas twice daily, once in the morning and once at night before bedtime, or as explicitly directed by a prescribing physician. Prior to initiating routine application, a skin sensitivity patch test should be performed: a small amount of cream is applied to an unbroken area of skin (such as the inner forearm) and evaluated over 24 hours. If minor erythema occurs without vesiculation or severe inflammation, therapy may proceed. Treatment duration is generally limited to several months; if no clinical improvement is observed after two months of continuous application, therapy should be discontinued and re-evaluated by the prescriber.

Adverse reactions

Application of Eukroma Cream may produce localized cutaneous adverse reactions. Common side effects include mild transient erythema, localized burning, stinging, dryness, pruritus, and localized contact dermatitis. In rare instances, prolonged exposure to high concentrations of hydroquinone can lead to exogenous ochronosis–a progressive blue-black hyperpigmentation of the dermal tissue, observed predominantly in darker skin types. Prolonged unmonitored use may also cause undesirable hyperpigmentation rebound or cutaneous atrophy. Patients must monitor the application site closely and report persistent or severe adverse reactions to their prescribing clinician immediately.

Precautions, Interactions, and Practical Use

Important precautions: Eukroma Cream is contraindicated in individuals with known hypersensitivity to hydroquinone, sodium metabisulfite (a common antioxidant excipient that may trigger allergic reactions in sensitive individuals), or any other ingredient in the vehicle formulation. Safety and efficacy in pediatric populations under 12 years of age have not been established. During pregnancy (FDA Pregnancy Category C), the cream should be used only if the potential benefit justifies the potential risk to the fetus, as systemic absorption data remains limited. Breastfeeding women should exercise caution, ensuring the cream is not applied to the chest or breast areas to prevent direct infant contact.

How it’s absorbed and eliminated: Following cutaneous application of Eukroma Cream to intact, healthy skin, systemic absorption of hydroquinone is minimal. Quantities that enter the systemic circulation undergo hepatic metabolism, primarily converting to glucuronide and sulfate conjugates. These water-soluble metabolites are subsequently excreted renally through the urine. Compromised dermal integrity or application over extensive surface areas can increase systemic absorption, elevating the risk of systemic metabolite accumulation.

Compatibility with other medicines: Concomitant topical use of Eukroma Cream with peroxide-containing agents, such as benzoyl peroxide or hydrogen peroxide, may result in temporary darkening or staining of the skin at the site of application. This discolored residue can usually be removed by washing the area with mild soap and water. Co-application with topical retinoids, alpha-hydroxy acids (AHAs), or exfoliative chemical agents can enhance skin irritation and dryness; such combinations should be managed under direct dermatological supervision to avoid skin barrier impairment.

First days of treatment: During the initial days of treatment with Eukroma Cream, mild localized sensation such as slight warmth, mild tingling, or minor redness may occur as the skin adjusts to the formulation. These early sensations generally subside within a short period. If severe itching, burning, swelling, or blistering develops during the first days, application should be stopped immediately, the cream washed off thoroughly, and a medical consultation arranged.

What to avoid while taking it: Ultraviolet radiation (UV light) stimulates melanocytes and directly counteracts the depigmenting effect of Eukroma Cream. Patients must avoid unnecessary sun exposure, tanning beds, and sunlamps during therapy. Daily morning application of a broad-spectrum sunscreen with an SPF of 30 or higher, alongside protective clothing (such as wide-brimmed hats), is mandatory on all treated areas exposed to natural sunlight.

Day-to-day use: Eukroma Cream should be applied gently and rubbed thoroughly into the hyperpigmented areas only. Avoid getting the cream into the eyes, nostrils, lips, open wounds, or mucous membranes. Hands should be washed thoroughly with soap and water immediately after application to prevent unintentional bleaching of non-targeted skin, such as fingertips or palms. Cosmetics may be applied over treated areas only after the cream has dried completely.

Storage and expiration: Store Eukroma Cream at controlled room temperature between 20°C and 25°C (68°F to 77°F), with short excursions permitted between 15°C and 30°C (59°F to 86°F). Keep the container tightly closed when not in use to prevent oxidation, which can cause the cream to darken. Do not freeze. Discard any cream that shows significant brown discoloration or past the printed expiration date located on the tube or packaging.

Common questions:

What happens if Eukroma Cream comes into contact with normal, non-pigmented skin?

Applying Eukroma Cream to non-hyperpigmented skin may cause localized lightening of normal skin tone. Care should be taken to apply the cream precisely to hyperpigmented spots to prevent unintentional depigmentation of surrounding skin.

How long can hydroquinone cream be safely applied consecutively?

Standard dermatological guidelines recommend limiting continuous application of prescription-strength hydroquinone to a maximum of 3 to 6 months per treatment cycle. Extended uninterrupted use increases the risk of exogenous ochronosis and therapeutic resistance. Medical evaluation determines whether cycling off the medication is necessary.

Is it safe to apply sunscreen or makeup directly over Eukroma Cream?

Yes, sunscreen and cosmetic products may be applied after Eukroma Cream has been fully absorbed into the skin. Patients should allow the cream to dry completely (typically a few minutes) before applying a broad-spectrum sunscreen or non-comedogenic makeup.

What steps should be taken if skin redness or peeling develops during treatment?

Mild erythema and light flaking are known side effects. However, if moderate to severe redness, scaling, or burning occurs, application frequency should be reduced, or the treatment temporarily paused. If severe skin irritation persists, consult the prescribing healthcare provider.

Does Eukroma Cream cause photosensitivity?

While hydroquinone itself is not a primary photosensitizing agent in the classical sense, depigmented skin lacks natural melanin protection and is significantly more susceptible to UV-induced erythema, sunburn, and recurrent hyperpigmentation. Rigorous sun protection is required throughout therapy.

Source and Disclaimer

In accordance with U.S. Food and Drug Administration (FDA) regulatory frameworks and general clinical practice standards.

This text is for informational purposes only and does not constitute individual medical advice.

Additional information
Dosage

20g

Package

1 tubes

,

2 tubes

,

3 tubes

,

4 tubes

,

5 tubes

,

6 tubes

,

7 tubes

,

8 tubes

,

9 tubes

,

10 tubes

Ενεργός Ουσία